MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

BIIE-0246

CAS No. : 246146-55-4

MCE 站：BIIE-0246

产品活性：BIIE-0246 是一种有效的、非肽神经肽 Y (NPY) Y₂ 受体的高度选择性拮抗剂，其 IC₅₀ 值为 15 nM。

研究领域：GPCR/G Protein  |  Neuronal Signaling

作用靶点：Neuropeptide Y Receptor

In Vitro: Receptor binding assays in HEK 293 cells transfected with the rat Y2 receptor cDNA demonstrate that BIIE-0246 competes with high affinity (IC₅₀=15±3 nM) against specific [¹²⁵I]PYY_3-36 binding sites. In contrast, BIIE-0246, at concentrations up to 10 μM, fails to compete for significant amounts of specific [¹²⁵I]GR231118, [¹²⁵I]hPP and [¹²⁵I][Leu³¹, Pro³⁴]PYY binding sites in HEK 293 cells transfected with the rat Y₁, Y₄ or Y₅ receptor cDNA, respectively.

In Vivo: On chow diet, genetically obese NPY mice show increased gain in body weight and adiposity. Treatment with BIIE-0246 promotes body weight gain in both genotypes after 4.5 weeks, and already at 2 weeks. BIIE-0246 has no significant effect on fat mass gain. In DIO, BIIE-0246 has different effects on body weight and composition depending on the genotype (treatment×genotype interaction in body weight P<0.05, in fat mass P<0.001 and in lean mass P<0.05). In DIO-WT group, post hoc analysis reveals increased body weight and fat mass gain, and a tendency to decrease lean mass gain. In DIO-NPY, BIIE-0246 inhibits fat mass gain (P=0.05). Interestingly, increased cholesterol levels are detected also in WT mice treated with BIIE-0246 for 2 weeks, but not in the 4.5-week cohort. In DIO-NPY mice in both treatment groups, cholesterol levels correlate positively with body fat mass (DIO-NPY vehicle P<0.01; DIO-NPY BIIE-0246 P<0.001), but not in any other group, and the slope of the regression curve of cholesterol and fat mass is significantly decreased in BIIE-0246-treated DIO-NPY group when compared with vehicle-treated group.

相关产品：Galanin (1-30), human  |  HT-2157  |  SHA 68  |  CGP71683 hydrochloride  |  RF9  |  Neuropeptide Y (human) (TFA)  |  BIBO3304 TFA  |  Velneperit  |  Galanin (1-16), mouse, porcine, rat TFA  |  M40  |  BIBP3226 TFA  |  BMS-193885  |  Galanin Receptor Ligand M35  |  Galantide  |  L 152804  |  Neuropeptide Y (3-36) (human, rat)  |  Neuropeptide Y(29-64)  |  RFRP-1(human)  |  [Leu31,Pro34]-Neuropeptide Y(human,rat) TFA  |  CYM 9484  |  Galanin (1-29)(rat, mouse)  |  GR231118  |  M1145  |  Neuropeptide S(Mouse)

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。